World's Best Scientists 2026 revealed!
Daniel C. Cattran

Daniel C. Cattran

D-Index & Metrics

Medicine

D-Index
97
Citations
31431
World Ranking
9364
National Ranking
369

Overview

Daniel C. Cattran is affiliated with the University Health Network in Canada. The primary area of their research is in Medicine, with a significant focus on Nephrology. Other notable subfields include Pathology and Forensic Medicine, Hematology, Immunology, and Rheumatology.

Their research concentrates on several key topics, notably:

  • Renal Diseases and Glomerulopathies
  • Chronic Kidney Disease and Diabetes
  • Platelet Disorders and Treatments
  • Systemic Lupus Erythematosus Research
  • Complement system in diseases
  • Autoimmune Bullous Skin Diseases
  • Systemic Sclerosis and Related Diseases

Frequent publication venues for Daniel C. Cattran include:

  • Kidney International
  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • UNC Libraries
  • Clinical Journal of the American Society of Nephrology

Several papers authored or co-authored by Cattran illustrate their research trajectory and collaborations. Key recent papers are:

  • The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis, 2020, Nature Communications
  • Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy, 2022, Kidney International
  • Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy, 2023, Nature Genetics
  • Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification, 2023, Kidney International
  • Why Target the Gut to Treat IgA Nephropathy?, 2020, Kidney International Reports

Daniel C. Cattran has collaborated extensively with several frequent co-authors, including:

  • Sean Barbour
  • Jonathan Barratt
  • Brad H. Rovin
  • Jai Radhakrishnan
  • Detlef Schlöndorff

Best Publications

  • The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification

    Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally

  • The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

    Ian S.D. Roberts;H. Terence Cook;Stéphan Troyanov;Charles E. Alpers

  • Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Daniel C. Cattran;John Feehally;H. Terence Cook;Zhi Hong Liu

  • Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group

    Hernán Trimarchi;Jonathan Barratt;Daniel C. Cattran;H. Terence Cook

  • Remission of Proteinuria Improves Prognosis in IgA Nephropathy

    Heather N. Reich;Stéphan Troyanov;James W. Scholey;Daniel C. Cattran

  • Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

    W. Kline Bolton;Daniel C. Cattran;Mark E. Williams;Sharon G. Adler

  • Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

    Laurence H. Beck;Fernando Custodio Fervenza;David M. Beck;Ramon G B Bonegio

  • Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

    Daniel C. Cattran;Gerald B. Appel;Lee A. Hebert;Lawrence G. Hunsicker

  • Predicting progression in IgA nephropathy.

    Lukasz P. Bartosik;Ginette Lajoie;Linda Sugar;Daniel C. Cattran

  • The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient.

    Jai Radhakrishnan;Daniel C. Cattran

  • Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

    Rosanna Coppo;Stéphan Troyanov;Shubha Bellur;Daniel Cattran

  • Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy The TESTING Randomized Clinical Trial

    Jicheng Lv;Jicheng Lv;Hong Zhang;Muh Geot Wong;Meg J. Jardine

  • Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    Fernando C. Fervenza;Gerald B. Appel;Sean J. Barbour;Brad H. Rovin

  • A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis

    Daniel C. Cattran;Gerald B. Appel;Lee A. Hebert;Lawrence G. Hunsicker

  • Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.

    Andrew S. Levey;Daniel Cattran;Aaron Friedman;W. Greg Miller

  • ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption

    Shazia Ashraf;Heon Yung Gee;Stephanie Woerner;Stephanie Woerner;Letian X. Xie

  • Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy: A Randomized Controlled Trial

    Andrew A. House;Misha Eliasziw;Daniel C. Cattran;David N. Churchill

  • Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

    Sean J Barbour;Rosanna Coppo;Hong Zhang;Zhi-Hong Liu

  • Impact of gender on the renal response to angiotensin II

    Judith A. Miller;Laurie A. Anacta;Daniel C. Cattran

  • Rituximab treatment of idiopathic membranous nephropathy.

    F.C. Fervenza;F.G. Cosio;S.B. Erickson;U. Specks

Frequent Co-Authors

John Feehally
John Feehally University of Leicester
Gerald B. Appel
Gerald B. Appel Columbia University
Agnes B. Fogo
Agnes B. Fogo Vanderbilt University Medical Center
Zhihong Liu
Zhihong Liu Nanjing University
Bruce A. Julian
Bruce A. Julian University of Alabama at Birmingham
Jeffrey B. Kopp
Jeffrey B. Kopp National Institutes of Health
Ian Roberts
Ian Roberts London School of Hygiene & Tropical Medicine
Loreto Gesualdo
Loreto Gesualdo University of Bari Aldo Moro
J. Charles Jennette
J. Charles Jennette University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees in the health field is a great way to diversify career options and gain specialized expertise. If you are considering alternatives or advancements beyond a traditional MD, there are several flexible online programs to consider.

For those interested in healthcare leadership, online mha programs affordable offer critical business and management skills needed in today’s hospitals and clinics.

Nursing professionals aiming for the highest level of practice may explore the best online dnp programs, which allow for advanced practice and leadership roles.

If pharmacy is your passion, consider pursuing pharmacy school online as a convenient way to achieve a Doctor of Pharmacy degree and broaden your impact in patient care.

Additionally, there is growing demand for professionals in health data management. Accredited him programs can prepare you for vital roles in electronic health records and information systems.

These online pathways can open doors to leadership, specialty, and technology careers throughout the healthcare sector.

Best Scientists Citing Daniel C. Cattran

Trending Scientists

Recently Published Articles